Kalvista Pharmaceuticals Inc (KALV.OQ)
KALV.OQ on NASDAQ Stock Exchange Global Market
18.67USD
2:29am IST
18.67USD
2:29am IST
Change (% chg)
$0.42 (+2.30%)
$0.42 (+2.30%)
Prev Close
$18.25
$18.25
Open
$18.33
$18.33
Day's High
$19.08
$19.08
Day's Low
$18.25
$18.25
Volume
49,223
49,223
Avg. Vol
28,679
28,679
52-wk High
$20.01
$20.01
52-wk Low
$5.65
$5.65
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2021 | Jul | 0.00 | -0.606 |
| FY 2020 | Apr '20 | 3.82 | -0.369 |
| Jan '20 | 1.58 | -0.521 | |
| Oct | 3.92 | -0.331 | |
| Jul | 3.37 | -0.420 | |
| FY 2019 | Apr '19 | 2.93 | -0.496 |
| Jan '19 | 3.89 | -0.230 | |
| Oct | 5.59 | -0.219 | |
| Jul | 3.72 | -0.466 | |
| FY 2018 | Apr '18 | 4.84 | -0.061 |
| Jan '18 | 2.33 | -0.485 | |
| Oct | 1.13 | -0.498 | |
| Jul | 0.10 | -0.507 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Apr-20 | 8 | 1.66 | 4.12 | 0.00 | -- |
| Quarter Ending Jan-21 | 6 | 0.42 | 2.50 | 0.00 | 4.14 |
| Year Ending Apr-20 | 8 | 10.54 | 12.98 | 8.87 | -- |
| Year Ending Apr-21 | 7 | 3.07 | 14.00 | 0.00 | 31.06 |
| Year Ending Apr-22 | 5 | 8.77 | 20.84 | 0.00 | 26.30 |
| Earnings (per share) | |||||
| Quarter Ending Apr-20 | 8 | -0.65 | -0.54 | -0.80 | -- |
| Quarter Ending Jan-21 | 6 | -0.70 | -0.55 | -0.93 | -0.39 |
| Year Ending Apr-20 | 8 | -1.94 | -1.81 | -2.11 | -- |
| Year Ending Apr-21 | 6 | -2.77 | -2.21 | -3.73 | -1.95 |
| Year Ending Apr-22 | 5 | -3.28 | -2.36 | -4.39 | -0.83 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 34.34 | 45.55 | |
| P/E High - Last 5 Yrs. | -- | 43.88 | 47.18 | |
| P/E Low - Last 5 Yrs. | -- | 25.20 | 25.19 | |
| Beta | 2.19 | 0.82 | 0.81 | |
| Price to Sales (TTM) | 35.06 | 4.46 | 12.72 | |
| Price to Book (MRQ) | 4.38 | 4.19 | 4.70 | |
| Price to Tangible Book (MRQ) | 4.39 | 4.85 | 6.34 | |
| Price to Cash Flow (TTM) | -- | 20.56 | 29.88 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.60 | 1.47 | |
| Dividend Yield - 5 Year Avg | -- | 1.62 | 15,705.26 | |
| Dividend 5 Year Growth Rate | -- | 4.39 | 5.15 | |
| Payout Ratio(TTM) | -- | 62.25 | 57.78 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -100.00 | 1.79 | 0.88 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -40.92 | 4.98 | 4.81 | |
| Sales - 5 Yr. Growth Rate | -- | 5.87 | 6.16 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -44.40 | 1.47 | 1.05 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -33.94 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 8.68 | 8.89 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 12.68 | 12.62 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.61 | 2.64 |
| Current Ratio (MRQ) | 9.49 | 3.55 | 3.56 |
| LT Debt to Equity (MRQ) | 0.00 | 13.82 | 16.41 |
| Total Debt to Equity (MRQ) | 0.00 | 18.53 | 21.33 |
| Interest Coverage (TTM) | -- | 8.69 | 12.85 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 55.18 | 54.78 | |
| Gross Margin - 5 Yr. Avg. | -- | 54.72 | 54.16 | |
| EBITD Margin (TTM) | -481.64 | -- | -- | |
| EBITD - 5 Yr. Avg | -- | 18.96 | 11.25 | |
| Operating Margin (TTM) | -487.21 | 14.40 | -14.33 | |
| Operating Margin - 5 Yr. Avg. | -- | 14.57 | 4.89 | |
| Pre-Tax Margin (TTM) | -350.99 | 14.64 | -17.17 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | 14.85 | 4.66 | |
| Net Profit Margin (TTM) | -349.66 | 10.89 | -20.84 | |
| Net Profit Margin - 5 Yr. Avg. | -- | 11.21 | 1.31 | |
| Effective Tax Rate (TTM) | -- | 18.00 | 18.82 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 22.12 | 22.23 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 166,446 | 951,947,350 | 812,121,067 | |
| Net Income/Employee (TTM) | -582,000 | 109,799,905 | 93,533,843 | |
| Receivable Turnover (TTM) | 0.74 | 5.72 | 5.91 | |
| Inventory Turnover (TTM) | -- | 2.56 | 3.76 | |
| Asset Turnover (TTM) | 0.09 | 0.82 | 0.80 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -31.99 | 10.54 | 9.42 | |
| Return on Assets - 5 Yr. Avg. | -- | 10.98 | 10.51 | |
| Return on Investment (TTM) | -35.94 | 13.09 | 12.28 | |
| Return on Investment - 5 Yr. Avg. | -- | 13.74 | 13.16 | |
| Return on Equity (TTM) | -36.97 | 14.71 | 13.53 | |
| Return on Equity - 5 Yr. Avg. | -- | 16.75 | 16.05 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -21.31 | 103.58 | -- |
| EPS (TTM) % | -18.85 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Kalvista Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 19.28 | 13.39 | 83 | 18 |
| 13 Week | 43.36 | 37.50 | 91 | 8 |
| 26 Week | 60.93 | 32.95 | 79 | 15 |
| 52 Week | 39.63 | 21.39 | 69 | 53 |
| YTD | 2.47 | -7.46 | 46 | 48 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 96.37% |
| # of Holders: | 110 |
| Total Shares Held: | 17,257,793 |
| 3 Mo. Net Change: | 284,361 |
| # New Positions: | 7 |
| # Closed Positions: | 15 |
| # Increased Positions: | 38 |
| # Reduced Positions: | 43 |
| # Net Buyers: | -5 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.